Allergy and allergic diseases

New England Journal of Medicine

Volumn 344, Issue 1, 2001, Pages 30-37

  Kay, A B ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; GENETIC PREDISPOSITION; HEALTH CARE COST; HELPER CELL; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ALLERGENS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INCIDENCE; INFLAMMATION; TH1 CELLS; TH2 CELLS; WESTERN WORLD;

EID: 0035804276     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200101043440106     Document Type: Review

References (62)

1. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991
2. A national estimate of the economic costs of asthma
3. Allergy
4. The subclass of IgG antibody in allergic disease. II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals
5. Human TH1 and TH2 subsets: Doubt no more
6. Nonallergic individuals recognize the same T cell epitopes of Bet v l, the major birch pollen allergen, as atopic patients
7. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression
8. Messenger RNA expression of the cytokine gene cluster interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects
9. H2-type broncho-alveolar T-lymphocyte population in atopic asthma
10. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia
11. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T cell responses toward the Th2 cytokine profile
12. The role of allergy in the development of asthma
13. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches
14. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance
15. GATA transcription factors expression in T cells, monocytes and bronchial biopsies of normal and asthmatic subjects
16. Prevalence of asthma and atopy in two areas of East and West Germany
17. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany
18. Give us this day our daily germs
19. Intestinal microflora of Estonian and Swedish infants
20. The intestinal microflora in allergic Estonian and Swedish 2-year-old children
21. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community
22. The alliance of genes and environment in asthma and allergy
23. Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma
24. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood
25. Predictors of asthma and persistent wheeze in a national sample of children in the United States: Association with social class, perinatal events, and race
26. Risk factors for asthma in inner city children
27. The epidemic of allergy and asthma
28. Peanut allergens
29. HLA-Dw2: A genetic marker for human immune response to short ragweed pollen allergen Ra 5. I. Response resulting primarily from natural antigenic exposure
30. A new variant of the β subunit of the high-affinity receptor for immunoglobulin E (FcεRI-β E237G): Associations with measures of atopy and bronchial hyper-responsiveness
31. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
32. Tumour necrosis factor haplotypes and asthma
33. A polymorphism in the 5′-flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
34. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
35. The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology
36. IgE-mediated allergen presentation via FcεRI on antigen-presenting cells
37. Blood eosinophils from atopic donors express messenger RNA for the α, β and γ subunits of the high-affinity IgE receptor (FcεRI) and intracellular, but not cell surface, α subunit protein
38. Induction and regulation of the IgE response
39. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
40. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2Rβ+ T cells
41. Antigen presentation is enhanced by targeting antigen to the FcεRII by antigen-anti-FcεRII conjugates
42. CD23/IgE-mediated regulation of the specific antibody response in vivo
43. Treatment of asthma with drugs modifying the leukotriene pathway
44. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES)
45. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
46. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin
47. Late cutaneous allergic responses in isolated IgE-dependent reactions
48. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions
49. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics
50. Interleukin-13: Central mediator of allergic asthma
51. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects
52. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor beta (TGF-β)
53. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase
54. Interleukin 5 regulates the isoform expression of its own receptor α-subunit
55. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF
56. Hemopoietic progenitors and cytokines in allergic inflammation
57. Nerve growth factor: An important molecule in allergic inflammation and tissue remodeling
58. The role of neurotrophins in allergic bronchial asthma
59. Neuropeptides
60. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics
61. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
62. Molecular identification of an IgE-dependent histamine-releasing factor